Reflected Cross-Site Scripting (XSS) in e107
Advisory ID: | HTB23220 |
Product: | e107 |
Vendor: | e107 |
Vulnerable Versions: | 2.0 alpha2 and probably prior |
Tested Version: | 2.0 alpha2 |
Advisory Publication: | June 18, 2014 [without technical details] |
Vendor Notification: | June 18, 2014 |
Vendor Fix: | June 27, 2014 |
Public Disclosure: | July 16, 2014 |
Latest Update: | July 16, 2014 |
Vulnerability Type: | Cross-Site Scripting [CWE-79] |
CVE Reference: | CVE-2014-4734 |
Risk Level: | Low |
CVSSv2 Base Score: | 2.6 (AV:N/AC:H/Au:N/C:N/I:P/A:N) |
Solution Status: | Fixed by Vendor |
Discovered and Provided: | High-Tech Bridge Security Research Lab |
Advisory Details: | |
High-Tech Bridge Security Research Lab discovered vulnerability in e107, which can be exploited to perform Cross-Site Scripting (XSS) attacks. | |
Solution: | |
Update e107_admin/db.php file from GitHub. More Information: https://github.com/e107inc/e107/commit/f80e417bb3e7ab5c1a89ea9ddd2cd060f54464e1 https://github.com/e107inc/e107/commit/e3088a877f94ac465555173e28b2f7f4a4f6d5e8 | |
References: | |
[1] High-Tech Bridge Advisory HTB23220 - https://www.immuniweb.com/advisory/HTB23220 - Reflected Cross-Site Scripting (XSS) in e107. [2] e107 - http://e107.org - Powerful Website Content Management System. [3] Common Vulnerabilities and Exposures (CVE) - http://cve.mitre.org/ - international in scope and free for public use, CVE® is a dictionary of publicly known information security vulnerabilities and exposures. [4] Common Weakness Enumeration (CWE) - http://cwe.mitre.org - targeted to developers and security practitioners, CWE is a formal list of software weakness types. [5] ImmuniWeb® - Leveraging the power of machine-learning and genius of human brain to deliver the most advanced web application security and penetration testing. [6] ImmuniWeb® SSLScan - Test your servers for security and compliance with PCI DSS, HIPAA and NIST. | |
HTB23215: Reflected Cross-Site Scripting (XSS) Vulnerability in Storesprite
Please feel free to send us any additional information related to this Advisory, such as vulnerable versions, additional exploitation details and conditions, patches and other relevant details.